Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

BACKGROUND: There is no currently available treatment for peritoneal metastasis of gastric cancer. This phase II study aimed to evaluate the efficacy and safety of neoadjuvant systemic chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Pengfei, Ye, Zeyao, Dai, Gaiguo, Zhang, Yanqiang, Huang, Ling, Du, Yian, Cheng, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667754/
https://www.ncbi.nlm.nih.gov/pubmed/33198674
http://dx.doi.org/10.1186/s12885-020-07601-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667754/
https://www.ncbi.nlm.nih.gov/pubmed/33198674
http://dx.doi.org/10.1186/s12885-020-07601-x

Ejemplares similares